These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1688228)

  • 21. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
    Dougall WC; Qian X; Peterson NC; Miller MJ; Samanta A; Greene MI
    Oncogene; 1994 Aug; 9(8):2109-23. PubMed ID: 7913542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
    Reddy CC; Wells A; Lauffenburger DA
    J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
    Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
    In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
    Lonardo F; Di Marco E; King CR; Pierce JH; Segatto O; Aaronson SA; Di Fiore PP
    New Biol; 1990 Nov; 2(11):992-1003. PubMed ID: 1983208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
    Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
    Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor.
    Witters L; Scherle P; Friedman S; Fridman J; Caulder E; Newton R; Lipton A
    Cancer Res; 2008 Sep; 68(17):7083-9. PubMed ID: 18757423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ErbB receptor activation, cell morphology changes, and apoptosis induced by anti-Her2 monoclonal antibodies.
    Kita Y; Tseng J; Horan T; Wen J; Philo J; Chang D; Ratzkin B; Pacifici R; Brankow D; Hu S; Luo Y; Wen D; Arakawa T; Nicolson M
    Biochem Biophys Res Commun; 1996 Sep; 226(1):59-69. PubMed ID: 8806592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.
    Mendelsohn J
    J Natl Cancer Inst Monogr; 1992; (13):125-31. PubMed ID: 1389685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
    Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
    Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of transforming growth factor-alpha and its receptor in the growth response of cultured human epidermal cells to retinoic acid.
    Piazza GA; Ritter JL
    Epithelial Cell Biol; 1993 Oct; 2(4):170-5. PubMed ID: 8269032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
    Karunagaran D; Tzahar E; Beerli RR; Chen X; Graus-Porta D; Ratzkin BJ; Seger R; Hynes NE; Yarden Y
    EMBO J; 1996 Jan; 15(2):254-64. PubMed ID: 8617201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
    Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG
    Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor.
    Azios NG; Romero FJ; Denton MC; Doherty JK; Clinton GM
    Oncogene; 2001 Aug; 20(37):5199-209. PubMed ID: 11526509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
    Bacus SS; Stancovski I; Huberman E; Chin D; Hurwitz E; Mills GB; Ullrich A; Sela M; Yarden Y
    Cancer Res; 1992 May; 52(9):2580-9. PubMed ID: 1373672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor.
    Chazin VR; Kaleko M; Miller AD; Slamon DJ
    Oncogene; 1992 Sep; 7(9):1859-66. PubMed ID: 1354348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of a novel growth factor from human breast cancer cells.
    Lupu R; Wellstein A; Sheridan J; Ennis BW; Zugmaier G; Katz D; Lippman ME; Dickson RB
    Biochemistry; 1992 Aug; 31(32):7330-40. PubMed ID: 1324710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2.
    Maier LA; Xu FJ; Hester S; Boyer CM; McKenzie S; Bruskin AM; Argon Y; Bast RC
    Cancer Res; 1991 Oct; 51(19):5361-9. PubMed ID: 1680547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.